BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12654768)

  • 1. Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the mid-west region of the Republic of Ireland.
    Gorman R; Adley CC
    J Antimicrob Chemother; 2003 Apr; 51(4):1047-9. PubMed ID: 12654768
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of nalidixic acid resistance for detecting salmonellae with decreased ciprofloxacin susceptibility.
    Albayrak F; Cokca F; Erdem B; Aysev AD
    Int J Antimicrob Agents; 2004 Apr; 23(4):332-6. PubMed ID: 15081080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones.
    Rodriguez-Avial I; Rodriguez-Avial C; López O; Picazo JJ
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):261-4. PubMed ID: 15893900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nalidixic acid resistance in Salmonella strains with decreased susceptibility to ciprofloxacin isolated from humans in Turkey.
    Ercis S; Erdem B; Hasçelik G; Gür D
    Jpn J Infect Dis; 2006 Apr; 59(2):117-9. PubMed ID: 16632912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Susceptibility to quinolones of Salmonella isolated from men and animals].
    Avril JL; Couete I; Travert MF; Autuly F; Plessis P
    Pathol Biol (Paris); 1995 Apr; 43(4):270-3. PubMed ID: 7567113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
    Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
    Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.
    Hakanen AJ; Lindgren M; Huovinen P; Jalava J; Siitonen A; Kotilainen P
    J Clin Microbiol; 2005 Nov; 43(11):5775-8. PubMed ID: 16272517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
    Ciraj AM; Seema DS; Bhat GK; Shivananda PG
    Indian J Pathol Microbiol; 2001 Oct; 44(4):407-8. PubMed ID: 12035350
    [No Abstract]   [Full Text] [Related]  

  • 9. Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the midwestern region of the Republic of Ireland due to mutations in the gyrA gene.
    Ryan MP; Dillon C; Adley CC
    J Clin Microbiol; 2011 May; 49(5):2077-9. PubMed ID: 21389151
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasmid-mediated quinolone resistance in Salmonella isolated from patients with overseas travelers' diarrhea in Japan.
    Taguchi M; Kawahara R; Seto K; Inoue K; Hayashi A; Yamagata N; Kamakura K; Kashiwagi E
    Jpn J Infect Dis; 2009 Jul; 62(4):312-4. PubMed ID: 19628914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant nontyphoidal Salmonella bacteremia, Thailand.
    Kulwichit W; Chatsuwan T; Unhasuta C; Pulsrikarn C; Bangtrakulnonth A; Chongthaleong A
    Emerg Infect Dis; 2007 Mar; 13(3):501-2. PubMed ID: 17552113
    [No Abstract]   [Full Text] [Related]  

  • 12. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
    Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quinolone resistance in Salmonella enterica].
    Seral C; López L; Castillo FJ; Clavel A; Rubio MC
    Rev Esp Quimioter; 1998 Mar; 11(1):43-6. PubMed ID: 9795288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance.
    Choi SH; Woo JH; Lee JE; Park SJ; Choo EJ; Kwak YG; Kim MN; Choi MS; Lee NY; Lee BK; Kim NJ; Jeong JY; Ryu J; Kim YS
    J Antimicrob Chemother; 2005 Dec; 56(6):1111-4. PubMed ID: 16244086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging quinolone-resistant Salmonella in the United States.
    Herikstad H; Hayes P; Mokhtar M; Fracaro ML; Threlfall EJ; Angulo FJ
    Emerg Infect Dis; 1997; 3(3):371-2. PubMed ID: 9284384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin resistance in non-typhoidal Salmonella serotypes in Scotland, 1993-2003.
    Murray A; Coia JE; Mather H; Brown DJ
    J Antimicrob Chemother; 2005 Jul; 56(1):110-4. PubMed ID: 15914492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluroquinolone resistance in typhoidal Salmonella and its detection by nalidixic acid disc diffusion.
    Anjum P; Qureshi AH; Rafi S
    J Pak Med Assoc; 2004 Jun; 54(6):295-301. PubMed ID: 15366793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models.
    Cebríán L; Rodríguez JC; Escribiano I; Royo SG
    APMIS; 2007 Dec; 115(12):1376-82. PubMed ID: 18184408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of resistance to quinolones in Salmonella enterica in our setting].
    Ruiz M; Sirvent E; Hernández C; Rodríguez JC; Royo G
    Rev Esp Quimioter; 1999 Dec; 12(4):366-8. PubMed ID: 10855017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH; Khan MA
    J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.